Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Mar 28;8(6):e1593811. doi: 10.1080/2162402X.2019.1593811

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2019 The Author(s). Published with license by Taylor & Francis Group, LLC.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

Figure 1. — Schematic representation of immune and inflammatory mediators selected and categorized by immune response type.

A literature search was conducted to identify secreted immune mediators associated with different categories of immune activation with known possible roles in cancer immunity. This identified 44 immune mediator markers (cytokines, chemokines, soluble inflammation and angiogenic factors), categorized into the following groups: Th1, Th2, Th9, Th17, M1 macrophage, M2 macrophage, anti-parasitic/infection response (immune activation genes, in orange), and, angiogenesis and inflammation (in blue) for evaluation of associations with patient survival in ovarian carcinoma.